Potent TGF-β Receptor Inhibitor for Pharmaceutical R&D | Manufacturer & Supplier
Discover a highly pure TGF-β receptor inhibitor (CAS 700874-72-2), also known as Galunisertib or LY2157299. This advanced pharmaceutical intermediate is critical for oncology research and drug development, offering potent TGF-βRI kinase antagonism. As a trusted manufacturer and supplier in China, we provide this essential compound for your innovative research.
Get a Quote & SampleAdvancing Oncology Research with a Key TGF-β Receptor Inhibitor
TGF-β Receptor Inhibitor (CAS 700874-72-2)
As a leading manufacturer and supplier in China, we provide high-purity Galunisertib (LY2157299). This TGF-βRI kinase antagonist is vital for pharmaceutical research, particularly in developing novel cancer therapies. Its potent activity in blocking TGF-β signaling pathways makes it an indispensable component for R&D.
- Potent TGF-β receptor 1 inhibition: Crucial for understanding and modulating cancer progression.
- High Purity Pharmaceutical Intermediate: Essential for reliable and reproducible research outcomes.
- Orally Bioavailable Compound: Facilitates in vivo studies and potential therapeutic applications.
- Supplier in China: Secure your supply chain with a reliable manufacturer for critical research compounds.
Key Advantages for Your Research & Development
Targeted TGF-β Pathway Modulation
This TGF-β receptor inhibitor effectively modulates critical signaling pathways involved in tumor growth, metastasis, and immune evasion, making it a prime candidate for cancer drug discovery.
Enhanced Immunotherapy Potential
Research indicates that this compound can reverse TGF-β-mediated suppression of T cell proliferation and enhance the efficacy of immunotherapies, offering new avenues for combination treatments.
Proven Pre-clinical and Clinical Utility
With documented use in clinical trials for various cancers, this pharmaceutical intermediate provides a strong foundation for your pre-clinical and clinical development strategies.
Diverse Applications in Pharmaceutical R&D
Oncology Drug Discovery
Investigate novel cancer treatments by targeting the TGF-β pathway. Buy this crucial TGF-β receptor inhibitor to advance your research.
Immunotherapy Enhancement
Explore combinations with checkpoint inhibitors and other immunotherapies. Source your LY2157299 from a trusted manufacturer for consistent results.
Pre-clinical and Clinical Studies
Utilize this high-purity intermediate in animal models and early-phase human trials. Inquire about our competitive price for bulk purchases.
Research & Development Intermediate
A critical building block for developing targeted therapies. Partner with a reliable supplier for your advanced pharmaceutical needs.